recombinant asparaginase

DRUG2 trials

Sponsors

medac GmbH

Conditions

Acute Lymphoblastic LeukemiaAcute Lymphoid Leukemia

Phase 2

Efficacy and Safety of Recombinant Asparaginase in Infants With Previously Untreated Acute Lymphoid Leukemia (ALL)

CompletedNCT00983138

medac GmbHAcute Lymphoid Leukemia

Start: 2009-07-31End: 2011-02-28Target: 12Updated: 2011-03-01

Phase 3

Comparative Efficacy and Safety of Two Asparaginase Preparations in Children With Previously Untreated Acute Lymphoblastic Leukaemia

CompletedNCT00784017

medac GmbHAcute Lymphoblastic Leukemia

Start: 2008-10-31End: 2012-10-31Updated: 2013-02-27

Related Papers

Efficacy and safety of recombinant <i>E. coli</i> asparaginase in children with previously untreated acute lymphoblastic leukemia: A randomized multicenter study of the Dutch Childhood Oncology Group

Pediatric Blood & Cancer2018-05-0422 citations